Clinical trial
Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes
NCT02597101
Study timeline
Study start (unknown)2015-11-01Date precision: month
Registry last updated2021-05-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Insulin Resistanceunresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
saxagliptinDRUG · verified · RxNorm: saxagliptin
AZD9668DRUG
placeboDRUG
Sponsors & collaborators
Nick Giannoukakis, PhDlead sponsor
National Institutes of Health (NIH)collaborator
University of Pittsburghcollaborator
University of South Floridacollaborator
AstraZenecacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02597101 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.